204 related articles for article (PubMed ID: 29417580)
1. In vivo characterization of brain metabolism by
Lai M; Vassallo I; Lanz B; Poitry-Yamate C; Hamou MF; Cudalbu C; Gruetter R; Hegi ME
Int J Cancer; 2018 Jul; 143(1):127-138. PubMed ID: 29417580
[TBL] [Abstract][Full Text] [Related]
2. Metabolic approach for tumor delineation in glioma surgery: 3D MR spectroscopy image-guided resection.
Zhang J; Zhuang DX; Yao CJ; Lin CP; Wang TL; Qin ZY; Wu JS
J Neurosurg; 2016 Jun; 124(6):1585-93. PubMed ID: 26636387
[TBL] [Abstract][Full Text] [Related]
3. Glucose fluxes in glycolytic and oxidative pathways detected in vivo by deuterium magnetic resonance spectroscopy reflect proliferation in mouse glioblastoma.
Simões RV; Henriques RN; Cardoso BM; Fernandes FF; Carvalho T; Shemesh N
Neuroimage Clin; 2022; 33():102932. PubMed ID: 35026626
[TBL] [Abstract][Full Text] [Related]
4. In vivo imaging of glucose consumption and lactate concentration in human gliomas.
Herholz K; Heindel W; Luyten PR; denHollander JA; Pietrzyk U; Voges J; Kugel H; Friedmann G; Heiss WD
Ann Neurol; 1992 Mar; 31(3):319-27. PubMed ID: 1637139
[TBL] [Abstract][Full Text] [Related]
5. Biopsy targeting gliomas: do functional imaging techniques identify similar target areas?
Weber MA; Henze M; Tüttenberg J; Stieltjes B; Meissner M; Zimmer F; Burkholder I; Kroll A; Combs SE; Vogt-Schaden M; Giesel FL; Zoubaa S; Haberkorn U; Kauczor HU; Essig M
Invest Radiol; 2010 Dec; 45(12):755-68. PubMed ID: 20829706
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic and prognostic value of 18F-DOPA PET and 1H-MR spectroscopy in pediatric supratentorial infiltrative gliomas: a comparative study.
Morana G; Piccardo A; Puntoni M; Nozza P; Cama A; Raso A; Mascelli S; Massollo M; Milanaccio C; Garrè ML; Rossi A
Neuro Oncol; 2015 Dec; 17(12):1637-47. PubMed ID: 26405202
[TBL] [Abstract][Full Text] [Related]
7. Independent thallium-201 accumulation and fluorine-18-fluorodeoxyglucose metabolism in glioma.
Oriuchi N; Tomiyoshi K; Inoue T; Ahmad K; Sarwar M; Tokunaga M; Suzuki H; Watanabe N; Hirano T; Horikoshi S; Shibasaki T; Tamura M; Endo K
J Nucl Med; 1996 Mar; 37(3):457-62. PubMed ID: 8772644
[TBL] [Abstract][Full Text] [Related]
8. MR-detectable metabolic biomarkers of response to mutant IDH inhibition in low-grade glioma.
Molloy AR; Najac C; Viswanath P; Lakhani A; Subramani E; Batsios G; Radoul M; Gillespie AM; Pieper RO; Ronen SM
Theranostics; 2020; 10(19):8757-8770. PubMed ID: 32754276
[TBL] [Abstract][Full Text] [Related]
9. Metabolic and transcriptomic profiles of glioblastoma invasion revealed by comparisons between patients and corresponding orthotopic xenografts in mice.
Cudalbu C; Bady P; Lai M; Xin L; Gusyatiner O; Hamou MF; Lepore M; Brouland JP; Daniel RT; Hottinger AF; Hegi ME
Acta Neuropathol Commun; 2021 Aug; 9(1):133. PubMed ID: 34348785
[TBL] [Abstract][Full Text] [Related]
10. [1-(13)C]glucose metabolism in the tumoral and nontumoral cerebral tissue of a glioma-bearing rat.
Bouzier AK; Quesson B; Valeins H; Canioni P; Merle M
J Neurochem; 1999 Jun; 72(6):2445-55. PubMed ID: 10349854
[TBL] [Abstract][Full Text] [Related]
11. A novel, integrated PET-guided MRS technique resulting in more accurate initial diagnosis of high-grade glioma.
Kim ES; Satter M; Reed M; Fadell R; Kardan A
Neuroradiol J; 2016 Jun; 29(3):193-7. PubMed ID: 27122050
[TBL] [Abstract][Full Text] [Related]
12. Multimodality In Vivo Imaging of Perfusion and Glycolysis in a Rat Model of C6 Glioma.
Qi Q; Fox MS; Lim H; Bartha R; Scholl TJ; Hoffman L; Lee TY; Thiessen JD
Mol Imaging Biol; 2021 Aug; 23(4):516-526. PubMed ID: 33534038
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of F-18-labeled amino acid derivatives and [18F]FDG as PET probes in a brain tumor-bearing animal model.
Wang HE; Wu SY; Chang CW; Liu RS; Hwang LC; Lee TW; Chen JC; Hwang JJ
Nucl Med Biol; 2005 May; 32(4):367-75. PubMed ID: 15878506
[TBL] [Abstract][Full Text] [Related]
14. In vivo
Lai M; Lanz B; Poitry-Yamate C; Romero JF; Berset CM; Cudalbu C; Gruetter R
J Cereb Blood Flow Metab; 2018 Oct; 38(10):1701-1714. PubMed ID: 29047296
[TBL] [Abstract][Full Text] [Related]
15. Changes in cerebral metabolism during ketogenic diet in patients with primary brain tumors:
Artzi M; Liberman G; Vaisman N; Bokstein F; Vitinshtein F; Aizenstein O; Ben Bashat D
J Neurooncol; 2017 Apr; 132(2):267-275. PubMed ID: 28074323
[TBL] [Abstract][Full Text] [Related]
16.
Rich LJ; Bagga P; Wilson NE; Schnall MD; Detre JA; Haris M; Reddy R
Nat Biomed Eng; 2020 Mar; 4(3):335-342. PubMed ID: 31988460
[TBL] [Abstract][Full Text] [Related]
17. Relative value of magnetic resonance spectroscopy, magnetic resonance perfusion, and 2-(18F) fluoro-2-deoxy-D-glucose positron emission tomography for detection of recurrence or grade increase in gliomas.
Prat R; Galeano I; Lucas A; Martínez JC; Martín M; Amador R; Reynés G
J Clin Neurosci; 2010 Jan; 17(1):50-3. PubMed ID: 19959364
[TBL] [Abstract][Full Text] [Related]
18. Comparison of magnetic resonance spectroscopy and positron emission tomography in detection of tumor recurrence in posttreatment of glioma: A diagnostic meta-analysis.
Wang X; Hu X; Xie P; Li W; Li X; Ma L
Asia Pac J Clin Oncol; 2015 Jun; 11(2):97-105. PubMed ID: 24783970
[TBL] [Abstract][Full Text] [Related]
19. Glutamate metabolism in temporal lobe epilepsy as revealed by dynamic proton MRS following the infusion of [U
Bartnik-Olson BL; Ding D; Howe J; Shah A; Losey T
Epilepsy Res; 2017 Oct; 136():46-53. PubMed ID: 28763722
[TBL] [Abstract][Full Text] [Related]
20. Multimodal elucidation of choline metabolism in a murine glioma model using magnetic resonance spectroscopy and 11C-choline positron emission tomography.
Wehrl HF; Schwab J; Hasenbach K; Reischl G; Tabatabai G; Quintanilla-Martinez L; Jiru F; Chughtai K; Kiss A; Cay F; Bukala D; Heeren RM; Pichler BJ; Sauter AW
Cancer Res; 2013 Mar; 73(5):1470-80. PubMed ID: 23345160
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
